fashion -WSS

fashion

author：knowledge 2025-09-06 08:25:03 - browse：6655

STAT's Megan Molteni speaks with Feng Zhang in New York on March 21, 2024 — Scientist Feng Zhang, right, is interviewed by reporter Megan Molteni at STAT's Breakthrough Summit East. STAT

When the first biotech companies emerged to capitalize on the revolutionary genome-editing technology CRISPR, Editas Medicine seemed like the pacesetter. It locked up some of the crucial IP, and had behind it the pioneering scientist Feng Zhang of the Broad Institute as one of its founders.

But now, a decade later, Editas is seen as lagging behind its peers. CRISPR Therapeutics, in partnership with Vertex Pharmaceuticals, won the race to get the first CRISPR-based medicine across the finish line. Intellia Therapeutics was the first to show that CRISPR editing could be performed inside the body. Editas, meanwhile, has seen a revolving door among its executives.

So what happened?

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Lawmakers grill UnitedHealth CEO on Change cyberattack

WSS

As health system earnings go up, health insurance stocks go down

Crinetics acromegaly drug succeeds in late

Can gargling with Listerine treat gonorrhea of the mouth?

How to fix cancer clinical trials' diversity problem

Class action alleges UnitedHealth concealed DOJ probe

How a small hospital in rural Puerto Rico survived Hurricane Maria

Wikipedia

fashion

Wikipedia

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How to fix cancer clinical trials' diversity problem

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Supreme Court strikes down use of affirmative action

The (many) problems with a new study criticizing cancer screening

As demand for Covid shots wanes, Moderna seeks its next success

Crowdfunding for medical bills sidesteps core problem, author says

Hepatitis C has a cure — but many Americans still lack access to it

Medicaid rebukes states for mistakenly disenrolling children

focus

Can gargling with Listerine treat gonorrhea of the mouth?

HHS's proposed rule does nothing to address the climate crisis

Illumina names Agilent executive as new CEO

House transparency, PBM reform bill gains bipartisan support

AltruBio raises $225 million to develop ulcerative colitis drug

Most antidepressants don't work on kids, teens, study finds

focus

focus

leisure time

explore